224 (Tiagabine hydrochloride 4 mg)
Pill imprint 224 has been identified as Tiagabine hydrochloride 4 mg.
Tiagabine is used in the treatment of seizures; bipolar disorder and belongs to the drug class gamma-aminobutyric acid reuptake inhibitors. Risk cannot be ruled out during pregnancy. Tiagabine 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
Tiagabine hydrochloride
- Imprint:
- 224
- Strength:
- 4 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sun Pharmaceutical Industries Ltd
- National Drug Code (NDC):
- 62756-0224
- Inactive Ingredients:
- butylated hydroxyanisole
lactose anhydrous
silicon dioxide
corn starch
magnesium silicate
crospovidone
hypromelloses
titanium dioxide
polyethylene glycol
lactose monohydrate
D&C Yellow No. 10
More about tiagabine
Consumer resources
- Other brands: Gabitril
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
